Table 1 Demographic, clinical and urological features of the patients with MS
Ranges | Totals | Women | Men | p value | |
|---|---|---|---|---|---|
Sex, N (%) | 109 (100.0) | 80 (73.4) | 29 (26.6) | ||
Age, mean ± SD | 24 – 67 | 44,6 ± 10,1 | 43,8 ± 9,0 | 44,3 ± 10,5 | NS |
RRMS, N (%) | 99 (90.8) | 73 (53.4) | 26 (89.6) | NS | |
SPMS, N (%) | 10 (9.2) | 7 (8.7) | 3 (10.3) | NS | |
EDSS, mean ± SD | 0.0 – 7.0 | 2,6 ± 1,7 | 2,5 ± 1,7 | 2,6 ± 1,8 | NS |
Disease duration (y), mean ± SD | 0.9 – 43 | 12,5 ± 8,7 | 12,6 ± 8,8 | 11,3 ± 8,8 | NS |
Immunomodulatory treatment, N (%) | 69 (63.3) | 50 (62.5) | 19 (65.5) | NS | |
Immunosuppressive treatment, N (%) | 6 (5.5) | 5 (6.2) | 1 (3.5) | NS | |
Untreated, N (%) | 34 (31.2) | 25 (31.3) | 9 (31.0) | NS | |
Patients with ≥1 urinary symptom, N (%) | 57 (52.3) | 39 (48.7) | 18 (62.1) | NS | |
1 symptom | 38 (65.5) | 24 (61.5) | 14 (77.7) | NS | |
2 symptoms | 15 (25.9) | 11 (27.5) | 4 (22.2) | NS | |
≥ 3 symptoms | 5 (8.6) | 5 (12.5) | 0 (0.0) | NS | |
Urgency | 44 (40.4) | 32 (40.0) | 12 (41.2) | NS | |
Frequency | 17 (15.6) | 13 (16.2) | 4 (13.8) | NS | |
Incomplete emptying | 13 (11.9) | 10 (12.5) | 3 (10.3) | NS | |
Hesitancy | 9 (8.3) | 8 (10.0) | 1 (5.5) | NS | |
Urge incontinence | 3 (3.7) | 3 (3.7) | 1 (3.5) | NS | |
Qmax, mean ± SD | 0 – 65 | 19.8 ± 11.2 | 21.1 ± 11.3 | 17.0 ± 7.1 | 0.029 |
Abnormal values (<15 ml/s), N (%) | 38 (34.9) | 26 (32.5) | 12 (41.4) | NS | |
PVR, mean ± SD | 0 – 1000 | 66.6 ± 82.1 | 64.6 ± 85.1 | 73.6 ± 75.1 | NS |
Abnormal values (<15 ml/s), N (%) | 44 (40.4) | 28 (35.0) | 16 (55.2) | NS | |
DSD, N (%) | 37 (33.9) | 32 (40.0) | 5 (17.2) | 0.016 |